Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT01076868
Eligibility Criteria:
Inclusion Criteria:
* Asymptomatic adults and children ≥ 6 months
* Documented P.vivax infection in the last 12 months who have not received radical treatment with primaquine
* Weight≥ 7 kg for children
* Participant (or parent/guardian if \<18 years old) is willing and able to give written informed consent
* Ability (in the investigators opinion) and willingness of patient or parent/guardian to comply with all study requirements
Exclusion Criteria:
* History of allergy to primaquine
* Medical conditions such as known chronic diseases (TB, HIV, cardio vascular diseases), allergies, mental illnesses and similar conditions that could make the interpretation of symptoms or the follow up difficult.
* Other conditions such as drug addiction, known poor compliance with treatment or follow up.
* Inability to tolerate oral medication
* Pregnancy
* G6PD deficiency
* Blood transfusion in the last 3 months
* Microscopic evidence of Plasmodium vivax, P.falciparum, P. malariae or ovale
* Fever ≥37.5C
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Study:
NCT01076868
Study Brief:
Protocol Section:
NCT01076868